|
US4166452A
(en)
*
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4217344A
(en)
|
1976-06-23 |
1980-08-12 |
L'oreal |
Compositions containing aqueous dispersions of lipid spheres
|
|
US4256108A
(en)
*
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4186183A
(en)
|
1978-03-29 |
1980-01-29 |
The United States Of America As Represented By The Secretary Of The Army |
Liposome carriers in chemotherapy of leishmaniasis
|
|
US4261975A
(en)
|
1979-09-19 |
1981-04-14 |
Merck & Co., Inc. |
Viral liposome particle
|
|
US4265874A
(en)
*
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
US4485054A
(en)
|
1982-10-04 |
1984-11-27 |
Lipoderm Pharmaceuticals Limited |
Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4946787A
(en)
|
1985-01-07 |
1990-08-07 |
Syntex (U.S.A.) Inc. |
N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
|
US4774085A
(en)
|
1985-07-09 |
1988-09-27 |
501 Board of Regents, Univ. of Texas |
Pharmaceutical administration systems containing a mixture of immunomodulators
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US4927838A
(en)
*
|
1987-07-10 |
1990-05-22 |
Hoffman-La Roche Inc. |
Pyridine compounds which are useful in treating a disease state characterized by an excess of platelet activating factors
|
|
US5010175A
(en)
|
1988-05-02 |
1991-04-23 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
|
IE66205B1
(en)
|
1990-06-14 |
1995-12-13 |
Paul A Bartlett |
Polypeptide analogs
|
|
US5650489A
(en)
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
|
US5593853A
(en)
|
1994-02-09 |
1997-01-14 |
Martek Corporation |
Generation and screening of synthetic drug libraries
|
|
US5539083A
(en)
|
1994-02-23 |
1996-07-23 |
Isis Pharmaceuticals, Inc. |
Peptide nucleic acid combinatorial libraries and improved methods of synthesis
|
|
US5525735A
(en)
|
1994-06-22 |
1996-06-11 |
Affymax Technologies Nv |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
|
US5549974A
(en)
|
1994-06-23 |
1996-08-27 |
Affymax Technologies Nv |
Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
|
|
US6537764B1
(en)
*
|
1995-01-19 |
2003-03-25 |
Children's Medical Center Corporation |
Method of identifying inhibitors of C—C chemokine receptor 3
|
|
US5569588A
(en)
|
1995-08-09 |
1996-10-29 |
The Regents Of The University Of California |
Methods for drug screening
|
|
SE9600820D0
(sv)
*
|
1996-03-01 |
1996-03-01 |
Pharmacia Ab |
Antibodies and their use
|
|
GB9712818D0
(en)
*
|
1996-07-08 |
1997-08-20 |
Cambridge Antibody Tech |
Labelling and selection of specific binding molecules
|
|
AU734090B2
(en)
|
1996-09-10 |
2001-06-07 |
Millennium Pharmaceuticals, Inc. |
CXCR3 chemokine receptor, antibodies, nucleic acids, and methods of use
|
|
US6140064A
(en)
*
|
1996-09-10 |
2000-10-31 |
Theodor-Kocher Institute |
Method of detecting or identifying ligands, inhibitors or promoters of CXC chemokine receptor 3
|
|
US5876946A
(en)
*
|
1997-06-03 |
1999-03-02 |
Pharmacopeia, Inc. |
High-throughput assay
|
|
EP0897980A3
(en)
|
1997-08-20 |
2002-04-17 |
Smithkline Beecham Corporation |
CXCR4B: A human splice variant of CXCR4 chemokine receptor
|
|
CA2242308A1
(en)
*
|
1997-12-08 |
1999-06-08 |
Smithkline Beecham Laboratoires Pharmaceutiques |
Novel compounds
|
|
US6306653B1
(en)
*
|
1998-01-20 |
2001-10-23 |
Codon Diagnostics, Llc |
Detection and treatment of breast disease
|
|
JP2002506830A
(ja)
*
|
1998-03-13 |
2002-03-05 |
ザ ユニバーシティ オブ ブリティッシュ コロンビア |
治療的ケモカイン受容体アンタゴニスト
|
|
ES2156581T5
(es)
|
1998-03-30 |
2015-01-21 |
Northwest Biotherapeutics, Inc. |
Aplicaciones terapéuticas y diagnósticas basadas en el papel del gen CXCR-4 en la tumorigénesis
|
|
US6287765B1
(en)
*
|
1998-05-20 |
2001-09-11 |
Molecular Machines, Inc. |
Methods for detecting and identifying single molecules
|
|
US6329510B1
(en)
*
|
1999-01-29 |
2001-12-11 |
Millennium Pharmaceuticals, Inc. |
Anti-CCR1 antibodies and methods of use therefor
|
|
US6329159B1
(en)
*
|
1999-03-11 |
2001-12-11 |
Millennium Pharmaceuticals, Inc. |
Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function
|
|
US6365356B1
(en)
*
|
1999-03-17 |
2002-04-02 |
Cornell Research Foundation, Inc. |
Receptors that regulate cell signaling relating to chemokines
|
|
US6448054B1
(en)
*
|
1999-04-08 |
2002-09-10 |
The General Hospital Corporation |
Purposeful movement of human migratory cells away from an agent source
|
|
US20020061599A1
(en)
*
|
1999-12-30 |
2002-05-23 |
Elling Christian E. |
Method of identifying ligands of biological target molecules
|
|
EP1263791A4
(en)
*
|
2000-02-09 |
2004-07-07 |
Human Genome Sciences Inc |
HUMAN G-PROTEIN CHEMOKIN RECEPTOR HDGNR10 (CCR5 RECEPTOR)
|
|
US20020064770A1
(en)
*
|
2000-03-21 |
2002-05-30 |
Nestor John J. |
Binding compounds and methods for identifying binding compounds
|
|
ES2336887T5
(es)
|
2000-03-30 |
2019-03-06 |
Whitehead Inst Biomedical Res |
Mediadores de interferencia por ARN específicos de secuencias de ARN
|
|
US20020025536A1
(en)
*
|
2000-06-26 |
2002-02-28 |
Jeno Gyuris |
Methods and reagents for isolating biologically active antibodies
|
|
US7442512B2
(en)
*
|
2001-11-30 |
2008-10-28 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US7413866B2
(en)
*
|
2001-11-30 |
2008-08-19 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
US7253007B2
(en)
*
|
2001-11-30 |
2007-08-07 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
|
AU2002358469A1
(en)
*
|
2001-12-21 |
2003-07-15 |
7Tm Pharma A/S |
Modified receptors for the discovery of therapeutic ligands
|
|
KR101061352B1
(ko)
*
|
2002-12-20 |
2011-08-31 |
케모센트릭스 |
인간 종양-발현된 ｃｃｘｃｋｒ2의 저해물질
|
|
WO2004062591A2
(en)
*
|
2003-01-06 |
2004-07-29 |
Oregon Health And Science University |
Methods of treatment and diagnosis of kaposi's sarcoma (ks) and ks related diseases
|
|
US9405700B2
(en)
|
2010-11-04 |
2016-08-02 |
Sonics, Inc. |
Methods and apparatus for virtualization in an integrated circuit
|
|
TWI552751B
(zh)
|
2011-06-20 |
2016-10-11 |
Ｈ 朗德貝克公司 |
投予４－（（１ｒ，３ｓ）－６－氯－３－苯基－二氫茚－１－基）－１，２，２－三甲基－哌及其鹽用於治療精神分裂症的方法
|